USFDA renews, expands use of Certara software to facilitate new drug & biologics regulatory review

Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced that the US Food and Drug Administration (FDA) has renewed, and in many [...]